Prostate cancer pill'ready within year'

A revolutionary pill offering new hope to men with aggressive prostate cancer could be available within a year.

Trial results were so promising that applications will now be made to market the drug abiraterone acetate worldwide as soon as possible.

The final trial was halted early on ethical grounds when it became clear that patients were doing far better than those given a placebo “dummy” drug.